Strategic Shifts & Business Growth

With a 30-year operations veteran retiring, Delta promotes a new president, COO, and CFO, betting on internal talent to navigate its future growth.

With mixed trial results for its obesity drug and rising costs, Skye Bioscience's upcoming 2025 earnings call is a pivotal moment for investors.

With $15M from top UAE families, TruDoc is scaling its 'hospital-at-home' model, signaling a major shift in how the GCC delivers critical care.

Record sales of its Trio® fertilizer fuel a major financial turnaround, as the company makes significant strides in extracting battery-grade lithium.

Backed by Shift4 and Castle Island, Cyclops aims to simplify stablecoin adoption for payment firms with a new, all-in-one platform.

Top tech vendors showcase AI-driven tools at the Business Architecture Innovation Summit, aiming to solve the high failure rate of corporate transformations.

The biotech plans to separate its R&D pipeline from its booming royalty assets, creating two public companies and winning applause from Wall Street.

As data centers face an energy crisis, a new exec hire at TRIMAX signals a strategic push into the lucrative secondary power market.

Two industry veterans with a shared history from the dawn of broadband are joining forces to help companies overcome California's complex regulatory barriers.

Apptegy's new AI-powered hub gives families instant answers, reduces staff workload, and turns parent questions into powerful data for school districts.

Jawhara Jewellers ditches bank loans for an $80M gold-for-gold lease, signaling a major shift in how the industry handles price volatility and risk.

In a tough market, Samuel Adams' Experienceship offers a lifeline of mentorship, funding, and collaborative brewing to small, independent craft brewers.

Known for baked makeup, Laura Geller Beauty launches a cream palette, targeting women 40+ with a hydrating formula and a star-studded, age-positive campaign.

As Akebia heads to a major conference, investors watch its Vafseo launch, new rare disease pipeline, and path to profitability. Here's what's at stake.

The soundtracking giant's new desktop app lets creators drag and drop music directly to their timeline, cutting production time and boosting flow.

NVIDIA invests billions in optics leader Coherent to secure the high-speed, US-made components needed to power the next generation of AI factories.

With positive Phase 3 data for its first-in-class Stargardt disease drug and a massive new financing round, Belite Bio pivots toward commercialization.

Mimosa Networks unveils new NLOS radios and a licensed spectrum strategy, targeting hard-to-reach areas and reshaping the fixed wireless broadband market.

TomoCredit offers an AI plan to turn tax refunds into credit growth, but reporting issues and a class-action lawsuit raise questions about its effectiveness.

Amid global chip uncertainty, PhotonIC debuts a multi-fab, multi-process platform designed to future-proof the optoelectronic supply chain for AI and cloud.